NEW YORK (GenomeWeb News) – Turku, Finland-based VTT today said that it is collaborating with Roche on research studies for an unnamed Roche cancer drug and potential predictive biomarkers.
 
VTT said the studies will use its high-throughput screening, RNA interference, cell biology, and bioinformatics capabilities. The firm said it would conduct the research at its facilities in Finland.
 
Terms of the alliance were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.